Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Guideline conform study with GLP.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1994
Report date:
1994

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Deviations:
no
GLP compliance:
yes
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Reference substance name:
barium(2+) dichloride dihydrate
EC Number:
600-412-6
Cas Number:
10326-27-9
IUPAC Name:
barium(2+) dichloride dihydrate
Details on test material:
- Name of test material (as cited in study report): barium chloride dihydrate
- EC number: 233-788-1
- Substance type: pure active substance
- Physical state: a whcitrey stalline granule or powder

Method

Species / strain
Species / strain / cell type:
Chinese hamster Ovary (CHO)
Details on mammalian cell type (if applicable):
no data available
Metabolic activation:
with and without
Metabolic activation system:
S9-mix
Test concentrations with justification for top dose:
Trial 1, without S9: 50, 160, 500 and 1600 µg/mL
Trial 1, with S9: 50, 160, 500, 1600 and 5000 µg/mL
Trial 2, without S9: 100, 250, 500, 1000, 1500 and 2000 µg/mL
Trial 2, with S9: 500, 1600, 3000, 4000 and 5000 µg/mL
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: no data
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
mitomycin C
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
cyclophosphamide
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium, duplicate cultures

DURATION (test without S9)
- Exposure duration: In the test without S9, cells were incubated with barium chloride dihydrate for 10 hours.
Spindel inhibitor: (cytogenetic assays): Colcemid was added and incubation continued for 2 hours.
Stain: (for cytogenetic assays): The cells were then harvested by mitotic shake-off, fixer, and stained with Giemsa.

DURATION (test with S9)
- Exposure duration: In the test with S9, cells were treated with barium chloride dihydrate and S9 for 2 hours, after which the treatment medium was removed and the cells were incubated for 10 to 11 hours in fresh medium.
Spindel inhibitor: (cytogenetic assays): Colcemid was added for the final 2 hours.
Stain: (for cytogenetic assays): The cells were then harvested by mitotic shake-off, fixer, and stained with Giemsa.

NUMBER OF CELLS EVALUATED: One hundred first-division metaphase cells were scored at each dose level. Classes of aberrations included simple (breaks and terminal deletions), complex (rearrangements and translocations), and other (pulverised cells, despiralised chromosomes, and cells containing 10 or more aberrations).

No further details are given.
Evaluation criteria:
no data
Statistics:
CA data are presented as percentage of cells with aberrations. To arrive at a statistical call for a trial, analyses were conducted on both the dose response curve and individual dose points. For a single trial, a statistically significant (P<0.05) difference for one dose point and a significant trend (P<0.015) are considered weak evidence for a positive response; significant differences for two or more doses indicate the trial is positive. A positive trend test in the absence of a statistically significant increase at any one dose results in an equivocal call (Galloway et al., 1987).

Results and discussion

Test results
Species / strain:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
no data
Remarks on result:
other: all strains/cell types tested

Applicant's summary and conclusion

Conclusions:
The in vitro chromosome aberration test in CHO cells was negative with and without metabolic activation.